A team led by Joan Brugge and Jason Zoeller from Harvard Medical School, USA, implanted human HER2+ breast tumor cells into the ducts of mouse mammary glands to recapitulate the architecture of ductal carcinoma in situ, a common type of non-invasive breast cancer. Here, ERBB2 is linked to breast neoplasm.